Aims: Dyspnea is the most common symptom experienced by patients with chronic obstructive pulmonary disease (COPD) and is linked to decreases in patient activity levels and quality of life. Use of standardized tools to measure dyspnea has a long history in respiratory care. However, in many cases it is not clear what is being quantified when using a particular tool. This review will consider the definition of and mechanisms believed to contribute to dyspnea, attempting to clarify what is being quantified in common tools currently available for dyspnea measurement. Chronic
Introduction
Dyspnea is the most common symptom experienced by patients with chronic obstructive pulmonary disease (COPD)'12 and is often associated with a change in the level of activity.3 Dyspnea in patients with COPD is frequently first reported in association with activities and progresses over time to also occur at rest. While the frequency of dyspnea may increase overtime, the intensity of dyspnea may not increase.4 However, continued daily activity limitations and changes in dyspnea intensity results in an inter-relationship of dyspnea affecting activities, and vice versa, often referred to as the 'dyspnea spiral'. Dyspnea intensity appears to play a key role in this cycle in that the greater the severity of dyspnea experienced with an activity, the more impact on quality of life. This cycle is a complex interchange between physiologic mechanisms, psychosocial issues, mood changes and reduction in daily activities. When dyspnea affects the performance of daily activities, the potential exists for important changes to occur in the individual's overall quality of life.5 In the implementation of many interventions used with individuals who have COPD, measurement and evaluation of dyspnea is an important part of its assessment. 7 Assessing dyspnea as an outcome may be murky, as frequently, regardless of the type of tool used to measure dyspnea there is a general perception that a reduction in dyspnea intensity or frequency has occurred, despite the fact that the instrument may not actually quantify either intensity or frequency. When dyspnea is quantified through standardized means, it is critical to know what that particular questionnaire, survey or instrument has captured, as not all dyspnea tools measure the same thing or are interchangeable. As with all measurements the tool used dictates what conclusions can be made about the results. A pivotal issue is whether the tool is attempting to quantify the current perceived intensity of dyspnea or the appraised impact of the dyspnea on activities of daily living (a secondary response). To appropriately measure dyspnea, it is important to appreciate its definition, the associated mechanisms, treatment implications, and then to carefully review the tool in light of this information, to understand if and how dyspnea intensity or impact might be quantified. Thus the purpose of this review is to clarify the measurement of dyspnea in terms of knowing what aspects of dyspnea has and has not been captured by a particular tool. Definition Dyspnea is a subjective experience, and thus the individual experiencing the symptom is the expert at when it occurs, intensifies or resolves. The definition published by the American Thoracic Society reflects this viewpoint:
Dyspnea is a term used to characterize a subjective experience of breathing discomfort that is comprised of qualitatively distinct sensations that vary in intensity. The experience derives from interactions among multiple physiological, psychological, social, and environmental factors, and may induce secondary physiological and behavioral responses.8
Dyspnea experienced with COPD contains this cascade of events from the point of initial intensity to secondary responses. Much of dyspnea measurement focuses on quantifying the secondary responses, particularly behavioral ones such as decreased activity. Few instruments attempt to quantify an individual's perception of these distinct sensations. In addition, secondary physiological responses clearly are those that have the potential to dramatically impact quality of life and translate into impairment and disability. Consequently, when attempting to select an instrument to measure dyspnea or when reviewing research that has used a particular dyspnea tool, it is important to determine what portion of this cascade of events the tool is attempting to quantify. All tools do not measure the same aspect of dyspnea.
Mechanisms
In individuals with COPD the pathophysiology believed to play a role in dyspnea is frequently summarized as a primary discrepancy between central respiratory motor activity and incoming signals from receptors in the airways, lungs, and chest wall structures. 8 For example, heightened ventilatory demand and impedance and potentially reduced respiratory muscle efficiency are common pathophysiological changes that can be a factor in dyspnea individuals with COPD experience. The American Thoracic Society consensus statement8 that defined dyspnea identified those mechanisms believed to play a potential role in dyspnea. Many familiar treatments that exist to minimize or alleviate dyspnea can be linked to these mechanisms. The troubling issue is that in many research reports, improvement in dyspnea is linked to the intervention, but we see no connection to the pathophysiologic mechanism believed to be at its source. This is particularly true in terms of the measurement tools used to quantify dyspnea and the potential ability to capture dyspnea as a result of that mechanism. For example, in many reports of pulmonary rehabilitation, a multifaceted longitudinal treatment for dyspnea and only one measure of dyspnea such as the Chronic Respiratory Disease questionnaire may be used.9 This instrument is a disease-specific measure of quality of life with a subscale that quantifies dyspnea as it results from individualized activities of daily living, clearly a secondary response. The treatment, in this case pulmonary rehabilitation, clearly impacted the secondary response to dyspnea experienced by the individuals who undertook it. However, it is not possible to determine which dyspnea mechanism was improved nor at what point in the course of treatment this occurred. Potentially this would be important if treatment plans were to be truly individualized and if the components of the treatment (e.g., exercise, education, and so on) were to be emphasized for their ability to ameliorate dyspnea. It is important to not only connect the mechanism and treatment, but the assessment of improvement as a result of that treatment through a measurement tool.
Nevertheless, it is not always clear how best to connect these facets, as it is not always clear the timeframe within which to expect an impact or if the change will be seen in the baseline symptom intensity (i.e., magnitude of dyspnea) or the impact it has on activities of daily life. The timeframe with which you can expect to see an intervention's effect is always a key consideration in how to assess and evaluate its impact. For dyspnea in particular, this is an unclear issue as in some cases the interventions may not reduce baseline dyspnea intensity, but the individual may be able to increase the numbers or add additional activities into their daily life. Table 1 suggests how the timeframe may be an important consideration in the quantification of dyspnea. For example, as mentioned earlier, pulmonary rehabilitation typically has a well-defined exercise program, which may see progressive improvements in dyspnea intensity and an educational component that may require a prolonged measurement timeframe to allow the individual to integrate the information into their daily life (Table 1) . Consequently, different measurement tools would need to be used if all components of the program are to be quantified as to their distinct impact on dyspnea. In particular it is critical in the selection of a dyspnea measurement tool to evaluate the impact of an intervention to determine whether the expected effect is relatively rapid (hours), intermediate (days to a few weeks), or prolonged (several weeks to months). Without linking the mechanism and intervention as well as careful evaluation of the timeframe of the expected outcome assessment and evaluation of dyspnea may fall short of expectations.
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Assessment and evaluation
Assessment and evaluation of any subjective experience is difficult and must rely on self-reports to quantify the intensity and impact. This holds true for dyspnea as well. A useful way to group self-report tools is to determine if they are to be used to discriminate between groups of individuals or evaluate change.10'11 Tools used to carefully measure different intensities of dyspnea would be an example of those that are discriminative while those that measure dyspnea as an outcome of any treatment are evaluative. Both types of instruments must have good documentation of traditional psychometric properties of reliability and validity. In addition to demonstrating reliability and validity, evaluative tools must be able to measure change.
Studies of a tool's responsiveness test its ability to measure change and must include some formal evaluation with a known change. These investigations can be multifaceted and controversial or relatively straightforward. For example, methods used to determine the value of clinically important differences are debatable12,13 and a full deliberation of these issues is beyond the scope of this review. For this review, values found in the literature will be reported; however, care must be taken to assess the responsiveness issues associated with any tool. In many cases, simple paired t-test or effect sizes are ample to evaluate the tool's responsiveness, but these cannot be generalized if there are not considerable similarities in population, treatment and methods. The important questions, regardless of the tool used, are 'is it necessary for the tool to capture the change' and 'can the tool do it'?
In addition to a full understanding of what the tool is capable of quantifying in terms of responsiveness, it is important to address the issues of timeframe, as well as scaling. The timeframe relates how the tool asks the respondent to report their dyspnea experience, referred to as the question framing. In other words, in eliciting the self-reports does the tool ask the respondent to consider the current level of dyspnea, or an amalgamation of the dyspnea over the last two weeks or some other extended period of time. As a general rule, tools that do not frame the questions in terms of a current state are ill-equipped to capture rapid change induced by a treatment. On the other hand, these same tools are typically better equipped to capture prolonged change than those asking for responses about the current state of dyspnea as they are less susceptible to daily variability. The scaling used by the tool is also an important issue to consider, particularly in relation to responsiveness. A tool with only five possible categories for selection may be less able to quantify discrete changes than a seven or even ten point scale. There is some debate over whether a ten point scale really provides greater definitive categories,14 but the general thought is that at a minimum, a ten point scale is as consistent as a seven point scale. 15 Consequently, it is important to examine what the tool's scaling is and if this would be adequate for the purpose for which it will be used. In general, question framing and scaling are important issues that must be considered in selecting a dyspnea tool and commonly are overlooked.
Based on these issues, it is possible to group dyspnea tools into three main categories: short-term intensity measures (current level of dyspnea); situation measures (standardized self-reports of dyspnea associated with specific daily activities); and impact measures (dyspnea measured in the context of quality of life) outlined in Table 2 . Some tools may overlap among categories since they may have properties of more than one category. ww.CRqwuraI.com Measurement of dyspnea in COPD PM Meek 33 For example the Chronic Respiratory Disease Questionnaire (CRQ) also has a dyspnea subscale that can be defined as a situation-based dyspnea tool, but when the total score of the instrument is used then this tool quantifies a broader impact measure of the symptom on the individual. Further, while most dyspnea tools ask respondents to rate their current intensity of dyspnea, some, such as the situation measures, evaluate dyspnea only related to specific activities, and are thus not 'clean' quantification of dyspnea intensity levels. For example the Medical Research Council (MRC) categorizes the individual based on whether dyspnea is associated with specific tasks and situations. Careful examination of these issues is needed to select the most appropriate tool to measure dyspnea in any particular situation. In the following section common examples of these types of tools will be discussed to further explicate the concerns surrounding knowing what a specific dyspnea tool provides in terms of measurement. This is not meant to be an exhaustive review of instruments, but an illustration of the measurement and psychometric issues using common dyspnea tools.
Short-term intensity tools
Short-term intensity dyspnea tools are those best prepared to deal with current states and treatments that have rapid effects. These tools are most commonly used to evaluate dyspnea before, during and after exposure to exercise. Given that increased physical effort results in increased metabolic demands, it is normal to expect dyspnea to increase with more strenuous exercise. Two scales have been particularly valuable at quantifying progressive increase in dyspnea during exercise and decrease over time as a result of an ongoing exercise program: the Borg Scale and the Visual Analog Scale (VAS).
The Borg Scale'6,17 is a category-ratio scale, which is most commonly used to quantify dyspnea in association with exercise. The modified scale has scale properties ranging from 0 = nothing at all to 10 = very, very severe, with descriptors between the numbers 0 and 10. (A number greater than 10 can be selected.) Descriptors have been modified so that '10' has been labeled 'extremely severe', or 'the worse possible dyspnea imaginable'. Reliability and validity have been reported in a general population 8 and in COPD patients.1920
The Borg has been used in intervention programs to evaluate dyspnea before, during and after progressive exercise. 9 Its usefulness and responsiveness in measuring dyspnea during exercise (e.g., treadmill), is well established, although the Borg Scale may not be responsive longitudinally. One investigator used the Borg Scale with maximum exercise at baseline, six months and one year and found no significant differences in patient ratings of dyspnea, despite improvements in the distance walked on a six-minute walk test722
The Visual Analog Scale (VAS)23 is usually a 100 mm line anchored at either end with a descriptor such as 'none' to 'very severe'. When used to measure dyspnea, these anchors are qualified to read 'no shortness of breath' to 'maximum shortness of breath', or some variation of this. The VAS has been shown to be equally valid by orienting the scale from the traditional horizontal to vertical.24 The VAS can be used to quantify a number of aspects of symptoms besides the sensation of dyspnea, such as effort and distress with dyspnea. One investigation using the VAS in this manner found that there was consistent difference between breathing distress and effort.25
Further use of the VAS in this manner was able to discriminate in this study between healthy individuals and those with asthma and COPD. Test-retest reliability26,27 and construct validity24 have been demonstrated. Evaluations of dyspnea with exercise using the VAS support its responsiveness, showing dyspnea to decrease followinp an intervention such as pulmonary rehabilitation. 26 2 Short-term intensity tools are excellent measures of dyspnea with exercise in a laboratory setting. Less is known about their responsiveness to change following intervention. Test-retest correlations have been low 26 (VAS, r = 0.54, Borg, r = 0.45). The Borg is particularly suited for the laboratory evaluation of dyspnea under controlled exercise conditions. The VAS, on the other hand, is a well-standardized test to measure multiple sensations associated with dyspnea. Theoretically, this would allow this method of quantification to be used to capture individual qualities of a sensation as described in the American Thoracic Society definition of dyspnea, although it has not been documented in the literature to be used in this manner other than to discriminate distress and effort.
Only one known tool exists that has been used to evaluate the qualities of the dyspnea sensation, the Breathing Descriptor tool. The Breathing Descriptor tool contains a list of descriptors that are answered on a scale from 0 (not at all) to 4 (extremely) in relation to how the responder currently feels. The descriptors were empirically derived for dyspnea from initial work on sensory dimensions28,29 such as air hunger, resistance to inspiration and expiration, feelings of suffocation, and sensations in the chest. Fifteen of the descriptors have undergone test-retest reliability evaluation in a sample of 218 individuals who sought care for difficulty 30 breathing. The percentage of agreement between the Aw.CRqcwnuI.cn Measurement of dyspnea in COPD PM Meek 34 urgent care setting and recall a few days later was quite good (79%) and supports that there is some consistency in descriptors used in at least urgent events and the recall of the sensations experienced. The tool has been used in a variety of ways, with the number of descriptors ranging from 13 to 19.31,32 However, in most cases the tool has been used to discriminate the qualities of the sensation given some sort of laboratory manipulation of breathing such as broncoprovocation or exercise and thus responsiveness has not been examined.33 34Furthermore, some evidence exists that ethnicity may produce differences in qualities of dyspnea sensations reported. 35 Nevertheless, this is the only tool that asks explicitly about the qualities of the sensation currently experienced by the respondent, but its use has been limited.
Situational measures
Situational dyspnea tools are those that quantify dyspnea in relation to a standard set of activities such as walking on level ground or up a hill. Situational measures are not as able to capture rapid change in current states or treatments that have rapid effects as they are linked to specific activities and a broader time frame. These tools have been used in several different ways, from sample stratification36 to measurement of prolonged change associated with medications37 or surgical intervention.38 Again, given the premise that increased physical effort results in increased metabolic demands, standardization of activities helps in discriminating respondents. Examples of situational dyspnea tools include the Medical Research Council (MRC), Oxygen Cost Diagram (OCD), Baseline Dyspnea Index (BDI) and the University of San Diego Shortness of Breath Questionnaire (SOBQ).
The Medical Research Council Scale (MRC) is a rating system indicating dyspnea associated with walking that produces a single score.39'40 Individuals are assigned to one of five grades, based on their difficulty with mobility, from Grade 1, never 'troubled by breathlessness except on strenuous activity', to Grade 5, 'too breathless to leave the house, or breathless after undressing'. The MRC does not measure dyspnea intensity itself, except as it relates to activities. This tool is easy to administer and useful for general screening and categorizing individuals. Its use in intervention programs to evaluate dyspnea is limited. The MRC has been shown to be somewhat responsive to surgical interventions, as approximately 80% of the participants improved by at least one MRC category.38
Other uses of the MRC include categorization of individuals for intervention. Test-retest,42 inter-rater reliability43 and content,44 and concurrent validity have 45 been reported. The MRC has only shown responsiveness in prolonged dramatic interventions and is not well suited to capture rapid changes. This may be due in part to the lack of clear differences between grades. 13 The Baseline Dyspnea Index (BDI), like the MRC, is a rater evaluation of dyspnea associated with activities.46
The rating includes the magnitude of the task, and effort to perform the task. Each category (item) is rated on a 0 to 4 grade and summated for a total score. The BDI also has a transitional score (TDI), which measures the change in dyspnea associated with activities following an intervention. The BDI (and TDI) rely on raters to evaluate/assign patient levels of dyspnea with activities.
The BDI has good inter-observer reliabiliy (weighted Kappa) of o.6547 to 0.7227 and validity4 correlating with the 12 MWD (r = 0.60). 48 The TDI has been shown to be responsive to rehabilitation4849 and longacting bronchodilators. 36 The BDI is used essentially to discriminate between individuals, while the TDI would be used to evaluate changes. The MRC and BDI/TDI are situational measures; both are completed as part of an interview with the respondent and the rater's impression is recorded. In both of these cases, because of the scoring methods as well as the link to specific activities, these measures must be classified as tools that quantify secondary responses and not either an initial respondent perception or unadulterated dyspnea intensity measure. Both of these tools, however, are generally easy to use, will capture intermediate to prolonged changes, and have demonstrated important uses in discriminating populations.
The University of San Diego Shortness of Breath Questionnaire (SOBQ) is a 24-item self-report tool that lists 21 activities.50'51 Respondents are asked to rate dyspnea linked with each activity from 0 = 'not at all' to 5 = 'maximally or unable to do because of breathlessness'. Respondents are asked to rate any activity they have not ever done with an estimation of the dyspnea they would experience if they performed the activity. In addition, respondents rate three general items related to dyspnea in their daily life. The SOBQ has shown good reliability taken over two days (testretest, r = 0.94), good internal consistency (cx = 0.91), and validity demonstrated through correlations with the six-minute walk distances (r = -0.47) and FEV1%pred (r = -0.28)52 The SOBQ has been shown to be responsive post rehabilitation53 and surgical intervention.54
The SOBQ is a unique situational self-report measure as it contains both situational (activity-linked) and general dyspnea perception questions. Potentially the general dyspnea perceptions questions provide this Chraiic Pepratory Dsse Measurement of dyspnea in COPD PM Meek 35 instrument with a means of capturing an initial perception of dyspnea that theoretically adds to its ability to capture more than just a secondary response to the symptom. However, these items are not separated from the activity component so it is not possible to determine the influence of these questions. These situational measures of dyspnea have been widely used with several types of interventions. Again, a limitation in using them is the rating or assignment of dyspnea associated with activities. This linkage of dyspnea with activities is useful to standardize for comparison purposes, but makes it impossible to separate activity level from dyspnea intensity. Thus, their use in evaluating dyspnea following any intervention must take this into consideration.
Impact measures of dyspnea
With the increased interest over the past decade in measuring the various effects of chronic respiratory disease on patients, a number of tools have been developed that evaluate the overall impact of COPD on quality of life. Some of these impact tools have items specific to dyspnea, others measure the several symptoms common to COPD, and still others more general activities and symptoms that impact on quality of life. Use of these tools to measure dyspnea may not be appropriate depending on the tool and should be considered carefully in light of the issues already mentioned. In addition, these measures are generally less specific to the dyspnea and are more complex to administer. Impact measures clearly attempt to capture a broad secondary response to the dyspnea and for the most part are used to measure intermediate to prolonged change. For the purposes of this review, only those tools that measure dyspnea separately versus as a composite symptom score will be discussed. The dyspnea impact tools that fit into this category are the CRQ and the Pulmonary Functional Status and Dyspnea Questionnaire (PFSDQ).
The CRQ is a 20-item, disease-specific quality of life questionnaire,5 which has been extensively used. The CRQ is interviewer-administered and contains four subscales (dyspnea, fatigue, emotional function and mastery) rated on a seven-point scale. The dyspnea subscale of the CRQ asks patients to identify five activities of importance to them, which are scored with I = most dyspnea and 7 = least. The CRQ has acceptable reliability (test-retest r = 0.73 but low internal consistency for dyspnea, oc = 0.53). 56 Recently, the CRQ has demonstrated its ability to be reliable in a selfcompletion format.57 The CRQ dyspnea subscale has been found to correlate with the VAS r = 0.66. The responsiveness of the CRQ has been established and an average change of 0.5 per item within a subscale is considered clinically important.59 '60 The CRQ has been widely tested as a measure of dyspnea with several different types of interventions, including pulmonary rehabilitation,62-65 inspiratory muscle training66 and inhaled steroids. 67 The CRQ has been criticized by some as not clinically useful, in part because of the difficulty in its administration. Further, because the activities are unique to the respondent, a comparison of dyspnea scores between studies and groups is dubious. However, this tool allows measurement of the secondary responses to dyspnea, both as it is associated with activity and from the standpoint of self-care with the mastery subscale. The tool has been successfully used in many situations to capture intermediate and prolonged changes and provides a unique approach to quantifying the impact of dyspnea. However, it is important to state that the tool in no way attempts to measure the initial response or intensity of dyspnea except as it relates to the individualized variables.
The PFSDQ is a 164-item, self-administered tool, which evaluates dyspnea and activity levels. The PFSDQ has good test-retest reliability on the dyspnea scale and the general dyspnea items (test-retest, r = 0.9470 and internal consistency of cx = 0.88-.94).68 The PFSDQ-M has also had good test-retest reliability on the dyspnea scale (test-retest, r = 0.83 and internal consistency of oc = 0.94).69 The PFSD(7 has been shown to be responsive to prolonged change, and to intermittent change following pulmonary 72 rehabilitation. Thus both have been used to discriminate and evaluate dyspnea, with the evaluations only tested with pulmonary rehabilitation. The PFSDQ and PFSDQ-M both provide a unique measure of the impact of dyspnea as it is linked to specific activities, but also a more general initial perception of dyspnea as measured by the general dyspnea component.
Summary and conclusions
Dyspnea is an important symptom associated with COPD. The use of established tools to measure intensity levels or changes associated with intervention is critically important. Many dyspnea tools are vww.CRqcumrI.com PM Meek 36 situational as they evaluate the dyspnea experienced with activities (e.g., BDI, SOBQ), while others build on this aspect and evaluate several dimensions of dyspnea, both associated and independent of activities (e.g., CRQ, PFSDQ, PFSDQ-M). Selection of the instrument to measure improvements in dyspnea must be carefully matched to the particular needs of the investigation or program and how dyspnea is to be focused on.
This review has highlighted several factors that may be overlooked but are essential if the tool's user is to understand the results. A general guideline to follow when selecting a tool is to carefully appraise what it is you want to capture, whether it be qualities of the sensation, initial perceptions or secondary responses and whether you want to evaluate the impact of some intervention. For example, if dyspnea management and energy conservation are strengths of a particular program, than a separate dyspnea tool with the potential to capture intermediate changes would be appropriate. Additionally, if an investigation wanted to evaluate dyspnea in relation to specific activities then a situational dyspnea tool with more specific activities might be needed. If the effect of improving exercise performance is on dyspnea impact then a disease-specific quality of life instrument might be in order. Nevertheless, whatever aspect of dyspnea is the focus, the users of a dyspnea tool must carefully appraise more than just the psychometric properties to fully understand the data obtained and what the tool is telling them.
